Trials / Completed
CompletedNCT01081327
Warfarin - How Good Are we at Maintaining Target Range ?
Observational Record Linkage Study Investigating Incidence of Adverse Events in Patients Anti-coagulated for Lone Atrial Fibrillation.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (actual)
- Sponsor
- University of Dundee · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Patients with atrial fibrillation are often anticoagulated with Warfarin. Warfarin has a narrow therapeutic window requiring frequent monitoring. This study aims to investigate the incidence of adverse events in the "real world" for patients receiving Warfarin for lone atrial fibrillation.
Conditions
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2010-03-05
- Last updated
- 2018-12-03
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01081327. Inclusion in this directory is not an endorsement.